- Global Pharma News & Resources

Press Releases - 2019-10-31

Date Title Company
31-Oct-2019 The Importance of "Shop and Compare" During Medicare Annual Election Period MDX Hawai'i
31-Oct-2019 Portage provides default status report Portage Biotech Inc.
31-Oct-2019 Curis to Release Third Quarter Financial Results and Hold Conference Call on November 5, 2019 Curis, Inc.
31-Oct-2019 New England Journal of Medicine Publishes Results from Astellas' Phase 3 ADMIRAL Trial of XOSPATA® (gilteritinib) in Adult Patients with FLT3 Mutation-Positive Relapsed/Refractory Acute Myeloid Leukemia(1) Astellas Pharma US, Inc.
31-Oct-2019 November International Hyperhidrosis Awareness Month: No Sweat, No Stress With the miraDry Treatment miraDry
31-Oct-2019 Watson-Marlow Fluid Technology Group’s puresu single-use tube assemblies offer reliable, sterile, customisable solutions for bioprocessing Watson-Marlow Fluid Technology Group
31-Oct-2019 OB-002 Significantly Reduces Bone Metastasis in a Murine Model of Breast Cancer Orion Biotechnology Canada, Ltd
31-Oct-2019 Vertex Announces European Medicines Agency Marketing Authorization Application Validation for VX-445 (Elexacaftor), Tezacaftor and Ivacaftor Combination Treatment in Cystic Fibrosis Vertex Pharmaceuticals
31-Oct-2019 New Study Illustrates the Limitations of Compounded Thyroid Hormones IBSA Pharma, Inc.
31-Oct-2019 Seneca Biopharma to Begin Trading Under New Ticker Symbol SNCA Seneca Biopharma, Inc.
31-Oct-2019 Seneca Biopharma to Begin Trading Under New Ticker Symbol SNCA Seneca Biopharma, Inc.
31-Oct-2019 RINVOQ™ (upadacitinib) Meets Primary and All Ranked Secondary Endpoints in Phase 3 Study in Psoriatic Arthritis AbbVie
31-Oct-2019 The Alliance for Regenerative Medicine Outlines Recommendations for Increasing the Number of European-Based ATMP Clinical Trials Alliance for Regenerative Medicine
31-Oct-2019 Aenitis Technologies and the Direction Générale de l'Armement (DGA) sign a partnership to develop a new AMSC-S project with a 1,2 million euros budget AENITIS TECHNOLOGIES
31-Oct-2019 Biophytis Files Protocol Amendment to Optimize the SARA-INT Phase 2b Clinical Trial for Sarcopenia Biophytis SA
31-Oct-2019 Sirnaomics to Present Preclinical STP705 Data Suggesting Reduction in Liver Fibrosis at AASLD Liver Meeting Sirnaomics, Inc.
31-Oct-2019 Bulletin from Moberg Pharma’s AGM on October 30th , 2019 Moberg Pharma
31-Oct-2019 ATP Assays Market Worth $315 Million by 2024 - Exclusive Report by MarketsandMarkets™ MarketsandMarkets
31-Oct-2019 Harley Street clinics to offer new brain stimulation treatment for depression Flow Neuroscience
31-Oct-2019 First NHS patient receives Chiesi’s advanced-therapy-medicinal product, Holoclar▼ for moderate-to-severe limbal stem cell deficiency (LSCD) caused by chemical or thermal eye burns Chiesi UK